Linical (2183) Q3 2025 earnings summary

Executive summary

• Net sales for the nine months ended December 31, 2024, decreased 14.0% year-over-year to ¥7,955 million, with growth in the US offset by declines in other regions.

• Operating profit dropped to ¥332 million from ¥641 million year-over-year, reflecting regional disparities in performance.

• Profit attributable to owners of parent was ¥316 million, up 24.8% year-over-year.

• Comprehensive income dropped to ¥217 million from ¥558 million year-over-year.

• The US segment showed increased sales and profit, while Japan, Europe, Korea, Taiwan, and China experienced declines.

Financial highlights

• Gross profit for the nine months was ¥1,857 million, down from ¥2,972 million year-over-year.

• Operating profit decreased 48.2% to ¥332 million.

• Ordinary profit declined 58.7% to ¥261 million.

• Net profit improved to ¥316 million from ¥253 million year-over-year.

• Extraordinary losses of ¥148 million were recorded, mainly from business restructuring expenses.

Outlook and guidance

• Full-year net sales forecast revised downward to ¥10,430 million, a 9.1% decrease from the previous forecast.

• Operating profit forecast reduced to ¥250 million, down 65.6% year-over-year.

• Net profit forecast lowered to ¥150 million, a 55.7% decrease year-over-year.

• Net income per share forecast for the year ending March 31, 2025, is ¥25.24.

• Dividend forecast for the year is ¥16 per share, unchanged from the previous announcement.